UPDATE 1-Merck reports data on experimental bone drug
September 19, 2011 at 18:29 PM EDT
Sept 19 (Reuters) - New data on Merck & Co Inc's experimental osteoporosis drug odanacatib show the highest dose of the drug improved bone mineral density in post-menopausal women after 5 years of continuous treatment, the company said on Monday.
